Ovarian granulosa cell apoptosis pathway

The ovarian granulosa cell apoptosis pathway is a fundamental physiological process that dictates the fate of ovarian follicles through the programmed cell death of granulosa cells (GCs). GCs are vital for oocyte development, providing physical support and producing essential steroids like estradiol; their apoptosis is the underlying mechanism of follicular atresia, which eliminates over 99% of follicles during a female's reproductive lifespan (PMID: 30631049). This pathway is regulated by an intricate balance of endocrine factors, such as Follicle-Stimulating Hormone (FSH), and paracrine factors like Bone Morphogenetic Proteins (BMPs), which activate survival signaling through the PI3K/Akt and MAPK/ERK pathways (PMID: 25108398). Conversely, pro-apoptotic triggers including oxidative stress, TNF-alpha, and the Fas/FasL system activate the caspase cascade (Caspase-3, 8, and 9) to execute cell death (PMID: 28753190). Clinical conditions such as Polycystic Ovary Syndrome (PCOS) and Primary Ovarian Insufficiency (POI) are often characterized by aberrant GC apoptosis, leading to follicular arrest or premature depletion of the ovarian reserve (StatPearls: NBK459328). Pharmacological management often targets this pathway indirectly using gonadotropins or GnRH analogs to promote GC survival and facilitate controlled ovarian stimulation in assisted reproductive technologies.

Other names

Granulosa cell apoptosisFollicular atresia pathwayGC apoptosisOvarian follicle atresia

Modulation of gonadotropin signaling (FSH/LH) to inhibit or promote granulosa cell survival and follicular development via the PI3K/Akt and MAPK/ERK signaling cascades.